Medication Recommendations for CABG Discharge
All patients discharged after CABG should receive aspirin (100-325 mg daily) initiated within 6 hours postoperatively and continued indefinitely, along with statin therapy to reduce LDL cholesterol to less than 100 mg/dL, and beta-blockers to prevent post-CABG atrial fibrillation. 1, 2
Core Medication Regimen
Antiplatelet Therapy
- Aspirin: 100-325 mg daily, initiated within 6 hours postoperatively and continued indefinitely
- Significantly improves saphenous vein graft patency rates
- Reduces occurrence of adverse cardiovascular events
- Dosing between 100-325 mg daily is efficacious 1
- P2Y12 inhibitor consideration:
- For patients with recent acute coronary syndrome (ACS) or stent placement before CABG: Add a P2Y12 inhibitor (clopidogrel, ticagrelor, or prasugrel) for 12 months 1, 3
- For patients at high risk of graft occlusion with low bleeding risk: Consider dual antiplatelet therapy 2, 4
- Clopidogrel 75 mg daily is a reasonable alternative for patients intolerant or allergic to aspirin 1
Lipid-Lowering Therapy
- Statins: All patients should receive statin therapy unless contraindicated 1
Other Essential Medications
- Beta-blockers: Should be administered to reduce incidence of postoperative atrial fibrillation 1, 2
- Nitroglycerin: Provide sublingual or spray formulation with clear instructions 1, 2
Special Considerations
For Patients with Diabetes
- Glucose control: Maintain blood glucose ≤180 mg/dL in the immediate postoperative period 1
- Continue appropriate diabetic medications after discharge
For Patients with Atrial Fibrillation
- Anticoagulation: Warfarin for 4 weeks is recommended for post-CABG atrial fibrillation persisting >24 hours 2
Patient Education and Follow-up
Provide clear written and verbal instructions about:
Refer all patients to cardiac rehabilitation programs 2
- Reduces cardiovascular mortality by 26% and overall mortality by 20%
Common Pitfalls to Avoid
Delayed initiation of aspirin: Benefits of aspirin on graft patency are lost if initiated >48 hours after surgery 1
Premature discontinuation of antiplatelet therapy: Particularly important for patients who had ACS or stent placement before CABG 5
Inadequate statin dosing: Ensure dose is sufficient to achieve target LDL reduction 1
Overlooking depression screening: Depression after CABG is associated with increased cardiac events and recurrent angina 2
Failure to provide clear instructions about nitroglycerin use and when to seek emergency care 1, 2
By following these evidence-based medication recommendations, the risk of graft occlusion, recurrent ischemic events, and mortality can be significantly reduced in patients discharged after CABG.